US Patent Issued to Merck Sharp & Dohme on Dec. 9 for "Tetrahydroquinazoline derivatives as selective cytotoxic agents" (Pennsylvania, New York, Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,183, issued on Dec. 9, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Tetrahydroquinazoline derivatives as selective cytotoxic agents" was invented by Antonella Converso (Elkins, Pa.), David N. Hunter (Hatfield, Pa.), Abdellatif El Marrouni (Ambler, Pa.), Anthony J. Roecker (Harleysville, Pa.), Anthony W. Shaw (Harleysville, Pa.), William D. Shipe (Chalfont, Pa.), Cheng Wang (Fort Washington, Pa.), Deping Wang (Sharon, Mass.) and Yunlong Zhang (Valhalla, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to tetrahydroquinazoline derivatives of Formula (I) and their use for selectively killing HIV infected...